Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 462901 - 462920 out of 476768 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 150MG/ML INJ,SOLN | 2 x 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AC22) spesolimab (adm: P, course dose) | SPEVIGO 150MG/ML INJ,SOLN | 2 x 1ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AE01) fingolimod (adm: O) | FINGOLIMOD 0.5MG CAP | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | XLCarePharmaceuticals,Inc. |
| USA | (L04AG03) natalizumab (adm: P) | TYSABRI 20MG/ML INJ | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AG05) vedolizumab (adm: P) | ENTYVIO 108MG/0.68ML INJ,SOLN,PEN | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAmerica,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 120ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 60ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 120ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX03) methotrexate | XATMEP 2.5MG/ML SOLN,ORAL | 60ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AzurityPharmaceuticals,Inc. |
| USA | (L04AX04) lenalidomide (adm: O) | LENALIDOMIDE 2.5MG CAP,ORAL | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (L04AX04) lenalidomide (adm: O) | LENALIDOMIDE 20MG CAP,ORAL | 21 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ExelanPharmaceuticals,Inc. |
| USA | (L04AX07) dimethyl fumarate (adm: O) | TECFIDERA 120MG CAP | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AX07) dimethyl fumarate (adm: O) | TECFIDERA 120MG CAP | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AX07) dimethyl fumarate (adm: O) | TECFIDERA 30 DAY STARTER KIT | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AX07) dimethyl fumarate (adm: O) | TECFIDERA 30 DAY STARTER KIT | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AX07) dimethyl fumarate (adm: O) | TECFIDERA 240MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AX07) dimethyl fumarate (adm: O) | TECFIDERA 240MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AX09) diroximel fumarate (adm: O) | VUMERITY 231MG CAP,EC | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | BiogenU.S.Corporation |
| USA | (L04AX09) diroximel fumarate (adm: O) | VUMERITY 231MG CAP,EC | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | BiogenU.S.Corporation |
Pages
